WWW - Posts tagged Valeant Pharmaceuticals at BloggingStocks

Valeant Pharmaceuticals posts

GlaxoSmithKline Gets Good News from FDA Regarding Epilepsy Drug

Posted Aug 12th 2010 1:40PM by Brent Archer (RSS feed)
Filed under: Good news, Options, Technical Analysis

GlaxoSmithKline (GSK - option chain) shares are rising today after the company said an FDA advisory panel unanimously backed its epilepsy drug, ezogabine. GSK codeveloped the drug with Valeant Pharmaceuticals (VRX). If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on AMGN.

GSK opened this morning at $37.17. So far today the stock has hit a low of $37.00 and a high of $37.39. As of 12:15, GSK is trading at $37.22 up 0.76 (2.1%). The chart for GSK looks neutral and S&P gives GSK a neutral 3 STARS (out of 5) hold ranking.

Continue reading GlaxoSmithKline Gets Good News from FDA Regarding Epilepsy Drug

Valeant Pharma (VRX) falls on bearish Barron's coverage

Posted Nov 23rd 2009 1:20PM by Brent Archer (RSS feed)
Filed under: Major Movement, Bad News, Newspapers, Magazines, Options, Technical Analysis

Valeant Pharmaceuticals (VRX - option chain) stock is trading lower today after an article in Barron's (subscription required) over the weekend said the company could see trouble ahead if its experimental epilepsy drug, which is undergoing the regulatory review process, is not profitable enough to offset declining royalties from its hepatitis C treatment. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on VRX.

This morning, VRX opened at $32.15. So far today the stock has hit a high of $32.95 and a low of $31.88. As of 11:30, VRX is trading at $32.07, down $1.21 (-3.6%). The chart for VRX looks bullish.

Continue reading Valeant Pharma (VRX) falls on bearish Barron's coverage